|
Conflicts of Interest in Clinical Trials |
|
|
|
Tuesday, 07 May 2002 |
|
Presented
by Vera Hassner Sharav
14th Tri-Service Clinical Investigation Symposium
Sponsored
by The U.S. Army Medical Department and
The Henry M. Jackson Foundation for the Advancment of Military Medicine
The
cornerstone of public trust in medical research is the integrity of
academic institutions and the expectation that universities, which rely
on public funding, have a responsibility to serve the public good. Financial
conflicts of interest affect millions of American people - those
who are subjects of clinical trials testing new drugs and those who
are prescribed drugs after their approval. |
|
Read more...
|
|
|
Protecting Human Subjects in Research: Are Current Safeguards Adequate? |
|
|
|
Tuesday, 23 April 2002 |
|
Current federal
regulations set no limits on the level of risk that a competent adult
may voluntarily choose to undertake for the sake of science. The regulations
require prior approval by a review board (IRB) to ensure the research
meets scientific and ethical justification, to ensure that the risks
and benefits (if any) are fully disclosed to the subject, and that
the subject can exercise the right to give or withhold informed consent. |
|
Read more...
|
|
|
Who is a Human Subject? Who has the Right to Informed Consent? |
|
|
|
Monday, 11 March 2002 |
|
"The
voluntary consent of the human subject is absolutely essential."
[Nuremberg
Code, 1947]
"Human
subject means a living individual about whom an investigator (whether
professional or student) conducting research obtains
(1)
data through intervention or interaction with the individual, or
(2)
identifiable private information.
[
Code of Federal Regulations 45 CFR 46.102 (f)]
On
October 30, 2001, the National Human Research Protection Advisory Committee
(NHRPAC) signed off on recommendations redefining the term "human
subject" in an effort to accommodate research that invades people's
privacy by declaring that "human subjects" are only those
"who interact personally with research investigators."
|
|
Read more...
|
|
|
Linguistic Tinkering with Regulatory Terminology Increases Risk of Harm for Children |
|
|
|
Monday, 28 January 2002 |
|
A cornerstone of the Declaration
of Helsinki (adopted by the World Medical Association in 1964, and reaffirmed
on Oct. 2000) is the distinction between research that is intended to
be "therapeutic" (potentially beneficial) to the subject and
"nontherapeutic" research, which is not intended to be beneficial
to the subject. The U.S. Code of Regulations affirms that distinction
for research involving children (45 CFR 46 Sections 405, 406), and the
U.S. Code affirms that distinction for the military (10 USC 980). |
|
Read more...
|
|
|
Conflicts of Interest Undermine Safety for Human Subjects |
|
|
|
Monday, 29 October 2001 |
|
Widely disparate
perspectives are presented in an article in the Maryland Daily Record
re: The Court of Appeals of Maryland decision (Gimes v Kennedy Krieger
Institute, Aug 16, 2001). That 6-to-1 landmark decision severely criticized
the practice of exposing healthy children to risks of harm in health
related research. Children, we must bear in mind, are powerless to exercise
that inviolable human right, the right to refuse to assume risks for
research.
Will this decision
undermine the legitimacy of research that puts healthy children at risk
in clinical trials? AHRP believes it will, and that the decision will
be sustained by other courts in other states. |
|
Read more...
|
|
|
|
<< Start < Prev 1 2 3 4 5 6 Next > End >>
|
| Results 37 - 45 of 51 |